🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being d...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-18
Trial ID
NCT01802918
Treatments Being Tested
GSK2838232 is a novel HIV-1 maturation inhibitor (MI) that is being develop...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-03-17
Trial ID
NCT03045861
Treatments Being Tested
The proposed study, 200207 is a double blind, placebo controlled, single an...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-11-18
Trial ID
NCT02289495
Treatments Being Tested
This study investigates the safety, tolerability and PKs of GSK2838232 with...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02289482
Treatments Being Tested
This study will be conducted in two Parts to confirm the acceptability/sele...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-08-02
Trial ID
NCT03234036
GSK2838232 is a Human Immunodeficiency Virus (HIV) maturation inhibitor bei...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03
Trial ID
NCT02795754
Treatments Being Tested